ED
AGN
Exane Derivatives’s Allergan plc AGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2
| Closed | -$354 | – | 734 |
|
|
2020
Q1 | $354 | Hold |
2
| – | – | ﹤0.01% | 603 |
|
|
2019
Q4 | $388 | Hold |
2
| – | – | ﹤0.01% | 602 |
|
|
2019
Q3 | $337 | Sell |
2
-26,438
| -100% | -$4.45M | ﹤0.01% | 581 |
|
|
2019
Q2 | $4.43M | Buy |
26,440
+25,679
| +3,374% | +$4.3M | 0.78% | 19 |
|
|
2019
Q1 | $111K | Sell |
761
-1,552
| -67% | -$227K | 0.02% | 272 |
|
|
2018
Q4 | $309K | Buy |
2,313
+1,821
| +370% | +$243K | 0.06% | 189 |
|
|
2018
Q3 | $93.9K | Sell |
492
-15,882
| -97% | -$3.03M | 0.02% | 308 |
|
|
2018
Q2 | $2.73M | Buy |
+16,374
| New | +$2.73M | 0.46% | 32 |
|
|
2018
Q1 | – | Sell |
-7,547
| Closed | -$1.24M | – | 628 |
|
|
2017
Q4 | $1.24M | Buy |
7,547
+5,883
| +354% | +$963K | 0.21% | 80 |
|
|
2017
Q3 | $341K | Buy |
1,664
+915
| +122% | +$187K | 0.06% | 141 |
|
|
2017
Q2 | $182K | Sell |
749
-1,361
| -65% | -$331K | 0.04% | 183 |
|
|
2017
Q1 | $504K | Buy |
2,110
+1,384
| +191% | +$331K | 0.11% | 122 |
|
|
2016
Q4 | $152K | Buy |
726
+725
| +72,500% | +$152K | 0.03% | 190 |
|
|
2016
Q3 | $230 | Buy |
+1
| New | +$230 | ﹤0.01% | 453 |
|
|
2015
Q2 | – | Sell |
-74,025
| Closed | -$22M | – | 519 |
|
|
2015
Q1 | $22M | Buy |
74,025
+73,863
| +45,594% | +$22M | 2.43% | 11 |
|
|
2014
Q4 | $41.7K | Buy |
+162
| New | +$41.7K | 0.01% | 300 |
|